510(k) K981801
K981801 is an FDA 510(k) premarket notification submitted by Princeton BioMeditech Corp. for the device "ACCUSIGN TCA, BIOSIGN TCA, STAUS DS TCA". The FDA issued a decision of Substantially Equivalent on Aug 25, 1998. The device falls under product code LFH (U.V. Spectrometry, Tricyclic Antidepressant Drugs), a Class II device regulated under 21 CFR 862.3910. Princeton BioMeditech Corp. has 71 other 510(k) clearances on record.
Clearance details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- Aug 25, 1998
- Date Received
- May 21, 1998
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device classification
- Device Name
- U.V. Spectrometry, Tricyclic Antidepressant Drugs
- Device Class
- Class II
- Regulation Number
- 862.3910
- Review Panel
- TX
- Submission Type
- 510(k)
Need the full FDA record for Princeton BioMeditech Corp.? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.